Vaccine to treat gum disease on the way

Vaccine to treat gum disease on the way

Melbourne, Australia — 10/12/2009

CSL Limited, Australia’s leading biopharmaceutical company, has today announced that a vaccine to treat severe gum disease is being developed in a new collaboration with Sanofi Pasteur, the world’s leading global manufacturer of vaccines.

CSL has signed an agreement with Sanofi Pasteur to fund a program in the CRC for the further development of a vaccine to prevent and treat the severe gum disease peridontitis.

Up to 30% of Australian adults suffer from the wide-spread gum disease, which causes gums to bleed and teeth to fall out. The condition has also been linked with heart disease, stroke, adverse pregnancy outcomes, dementia and cancer.

Download the Release:
PDF icon Vaccine to treat gum disease on the way (0.25MB)

Additonal Information:
Visit the CRC for Oral Health Sciences Website to find out more.

Media Contacts:

Dr Rachel David
Director of Public Affairs
CSL Limited
Phone: +61 401 775 779

Rebecca Scott
Media Officer
University of Melbourne
Phone: +61 417 164 791

Daniella Goldberg
Oglivy PR Health
Phone: +61 416 211 067
© 2017 CSL Limited